Effectiveness of Phone Call and Video-based Interventions to Improve Adherence to Medications in Hypertensive Patients
Effectiveness, Cost-effectiveness, and Acceptability of Phone Call and Video-based Interventions to Improve Adherence to Antihypertensive Medications
1 other identifier
interventional
1,400
1 country
1
Brief Summary
The goal of this clinical trial is to find out if phone call and video-based interventions that seek to educate people with uncontrolled high blood pressure and also remind them to take their medicines will improve adherence to their medicines. It will also examine if the interventions are economical to implement. The main objectives of the study are:
- Design videos and phone call-based interventions for people with hypertension.
- Examine the effect of videos and phone call-based intervention on adherence to medication in people with hypertension.
- Calculate the costs associated with the mobile health intervention
- Examine the factors influencing acceptance of video and phone calls based interventions for improving adherence to antihypertensive medications among patients Participants will:
- Receive the intervention thrice weekly for 3 months
- Visit the health facility at the end of 3 months for check up and measurement of outcome variables (adherence and blood pressure). Additionally, at the end of 3 months, the acceptability of the interventions will be measured among the participants who received either phone call or video. Researchers will compare the two groups (one group will utilize phone call whereas the other videos) with the control group to see if the mobile interventions improve adherence to medicines. Only adults 18 years and above in selected health facilities in the Eastern will participate in the study. The selected participants should have uncontrolled blood pressure based on readings from last 2 visits. To be included in the study, the participants need to own a smartphone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hypertension
Started Feb 2025
Shorter than P25 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 17, 2025
CompletedStudy Start
First participant enrolled
February 24, 2025
CompletedFirst Posted
Study publicly available on registry
April 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2025
CompletedApril 15, 2025
February 1, 2025
6 months
January 17, 2025
April 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
change in systolic blood pressure
The systolic blood pressure at baseline will be compared to the systolic pressure at endline. This will help to determine if the intervention has an effect on the blood pressure
baseline and 3 months
Medication adherence measured using the Morisky Medication Adherence Scale-8(MMAS-8)
Medication adherence will be measured at baseline and then after administering the intervention. MMAS-8 has eight items on the scale. The first seven (7) items on the scale require a yes or no response whereas the eighth item uses a five-point Likert scale (never/rarely to all the time). The total score ranges from 0 to 8 with a score of \<6 indicative of non-adherence. A score between 6 \< 8 indicates medium adherence whereas a score of 8 shows high adherence.
baseline and 3 months
Secondary Outcomes (2)
Proportion of patients with controlled blood pressure
baseline and 3 months
Acceptability of the intervention
3 months
Study Arms (3)
the video-group
ACTIVE COMPARATORIn this arm, participants with uncontrolled blood pressure will receive videos via WhatsApp to educate them about the condition hypertension, side effects of medications and also remind them to take their medications. The intervention will be administered on days and time convenient for the patient and will be administered thrice weekly for 3 months. Participants in this group will receive the video intervention in addition to usual care (which is the care they receive from health facilities)
the phone call group
ACTIVE COMPARATORIn this arm, participants with uncontrolled blood pressure will receive phone calls to educate them about the condition hypertension, side effects of medications and also remind them to take their medications. The intervention will be administered on days and time convenient for the patient and will be administered thrice weekly for 3 months. Participants in this group will receive the phone call intervention in addition to usual care (which is the care they receive from health facilities)
control group
PLACEBO COMPARATORThis group will neither receive phone call or videos. The group will only receive a message that indicates that they are being enrolled into the study.
Interventions
The phone call based intervention seek to educate patients about hypertension and the medications used. It also seeks to remind patients to take their medications. This will be done thrice weekly
The video based intervention seek to educate patients about hypertension and the medications used. It also seeks to remind patients to take their medications. This will be done thrice weekly
The usual care concerns the care the participants receive from the health facility. Participants in this group would neither receive the phonecall or video based interventions.
Eligibility Criteria
You may qualify if:
- adult aged 18 years or older
- diagnosed of hypertension
- has uncontrolled hypertension (i.e. systolic blood pressure ≥140 mmHg and a diastolic blood pressure ≥ 90mmHg) documented in their records on 2 clinic visits
- has been prescribed at least one antihypertensive medication for a period of 2 months before the study
- owns a smart phone or has access to one at all times.
You may not qualify if:
- Pregnant women with hypertension or within 3 months postpartum
- Hypertensive patients with diabetes, liver failure or kidney disease
- Plans to travel out of the country during the period of the study
- Participating in another mobile health intervention or medication adherence intervention
- has a psychiatric disease or mental illness 6) has a visual impairment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St Joseph Catholic Hospital
Efiduase, Koforidua, Ghana
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Patrick Asuming, PhD
University of Ghana
- STUDY CHAIR
Gordon Abekah-Nkrumah, PhD
University of Ghana
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 17, 2025
First Posted
April 15, 2025
Study Start
February 24, 2025
Primary Completion
August 30, 2025
Study Completion
August 30, 2025
Last Updated
April 15, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- The study protocol will be available
- Access Criteria
- The study protocol will be available online to all. The study protocol will be shared through publications.
Data set or information that will be shared include study protocol